Lineage Cell Therapeutics, Inc. (TLV: LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
317.90
-6.10 (-1.88%)
Oct 15, 2024, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 591.68 million as of October 16, 2024. Its market cap has decreased by -24.87% in one year.
Market Cap
591.68M
Enterprise Value
452.54M
Revenue
23.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
317.90
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 591.68M, an increase of 1,096.53%. That is a compound annual growth rate of 7.94%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition